Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cambridge, Massachusetts
Biotech
AZ hopes for ‘amazing things’ from Kendall Square R&D center
AstraZeneca execs touted the benefits of embedding themselves in Massachusetts’ biopharma “ecosystem” as the Big Pharma opened a new R&D center.
Julia Sklar
Oct 6, 2026 5:30am
GSK to move vaccine R&D group from Maryland to Massachusetts
Feb 12, 2025 11:27am
Astellas’ new lab zooms in on targeted protein degradation
Sep 5, 2024 12:01pm
Atlas lands $450M fund to build fresh batch of biotechs
Mar 3, 2022 9:10am
Charles River expands development lab space in Cambridge
Oct 20, 2021 3:25pm
Massachusetts biopharmas raise $4.3B in 1Q
Aug 25, 2021 8:51am
